AU2003263993A1 - MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USE - Google Patents
MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USEInfo
- Publication number
- AU2003263993A1 AU2003263993A1 AU2003263993A AU2003263993A AU2003263993A1 AU 2003263993 A1 AU2003263993 A1 AU 2003263993A1 AU 2003263993 A AU2003263993 A AU 2003263993A AU 2003263993 A AU2003263993 A AU 2003263993A AU 2003263993 A1 AU2003263993 A1 AU 2003263993A1
- Authority
- AU
- Australia
- Prior art keywords
- mp2153s
- modifiers
- pathway
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4739—Cyclin; Prad 1
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40170102P | 2002-08-07 | 2002-08-07 | |
US60/401,701 | 2002-08-07 | ||
US41101702P | 2002-09-16 | 2002-09-16 | |
US60/411,017 | 2002-09-16 | ||
US43710702P | 2002-12-30 | 2002-12-30 | |
US60/437,107 | 2002-12-30 | ||
PCT/US2003/024505 WO2004015069A2 (en) | 2002-08-07 | 2003-08-06 | MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USE |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003263993A8 AU2003263993A8 (en) | 2004-02-25 |
AU2003263993A1 true AU2003263993A1 (en) | 2004-02-25 |
Family
ID=31721494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003263993A Abandoned AU2003263993A1 (en) | 2002-08-07 | 2003-08-06 | MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USE |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003263993A1 (en) |
WO (1) | WO2004015069A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014162962A1 (en) * | 2013-04-01 | 2014-10-09 | 学校法人 久留米大学 | Tumor antigen peptide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821072A (en) * | 1996-02-20 | 1998-10-13 | Sloan-Kettering Institute For Cancer Research | Combinations of PKC inhibitors and therapaeutic agents for treating cancers |
US6071696A (en) * | 1996-12-30 | 2000-06-06 | The Trustees Of Columbia University In The City Of New York | Method of producing a temporally spaced subtracted (TSS) CDNA library and use thereof to monitor differentiation |
-
2003
- 2003-08-06 WO PCT/US2003/024505 patent/WO2004015069A2/en not_active Application Discontinuation
- 2003-08-06 AU AU2003263993A patent/AU2003263993A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003263993A8 (en) | 2004-02-25 |
WO2004015069A3 (en) | 2004-09-02 |
WO2004015069A2 (en) | 2004-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003213606A1 (en) | MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2002310256A1 (en) | Ppp2cs as modifiers of the p53 pathway and methods of use | |
AU2002324598A1 (en) | Trps as modifiers of the p53 pathway and methods of use | |
AU2002314887A1 (en) | Gads as modifiers of the p53 pathway and methods of use | |
AU2003248879A1 (en) | RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2002316631A1 (en) | Ube2s as modifiers of the p21 pathway and methods of use | |
AU2003272400A1 (en) | Syts as modifiers of the p21 pathway and methods of use | |
AU2003265263A1 (en) | ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
AU2003295881A1 (en) | Lamps as modifiers of the p53 pathway and methods of use | |
AU2003263993A1 (en) | MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USE | |
AU2003258095A1 (en) | MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
AU2003251826A1 (en) | Mp21s as modifiers of the p21 pathway and methods of use | |
AU2003303094A1 (en) | MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003274911A1 (en) | Mrbs as modifiers of the rb pathway and methods of use | |
AU2003223208A1 (en) | MP21s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
AU2003248876A1 (en) | MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003278811A1 (en) | LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2002354668A1 (en) | Modifiers of the p21 pathway and methods of use | |
AU2003294499A1 (en) | Rhebs as modifiers of the rb pathway and methods of use | |
EP1578945A3 (en) | Cct6s as modifiers of the rb pathway and methods of use | |
AU2002345486A1 (en) | Slc13as as modifiers of the p53 pathway and methods of use | |
AU2002312283A1 (en) | Srpks as modifiers of the p53 pathway and methods of use | |
AU2002303951A1 (en) | Glras as modifiers of the p53 pathway and methods of use | |
AU2002303947A1 (en) | Pecis as modifiers of the p53 pathway and methods of use | |
AU2002357817A1 (en) | Klcs as modifiers of the p53 pathway and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |